Chinese Journal of Pharmacovigilance ›› 2019, Vol. 16 ›› Issue (11): 695-696.
DOI: 10.19803/j.1672-8629.2019.11.11
Previous Articles Next Articles
LIU Xiaoli, LIU Yajuan, CAO Yidan, SONG Yanqing, WANG Xiangfeng*
Received:2019-11-27
Revised:2019-11-27
Online:2019-11-20
Published:2019-11-27
CLC Number:
LIU Xiaoli, LIU Yajuan, CAO Yidan, SONG Yanqing, WANG Xiangfeng. One Case of Systemic Urticaria Complicated with Dyspnea Induced by Moxifloxacin Hydrochloride Injection[J]. Chinese Journal of Pharmacovigilance, 2019, 16(11): 695-696.
| [1] 赵东玲,屈清慧,李瑞林,等. 莫西沙星致不良反应3445例文献分析[J]. 中国药房, 2015, 26(21) :2913-2915. [2] 郑芸颖,王华光,陈罡,等. 莫西沙星注射液导致全身皮疹的迟发型过敏反应[J]. 中国临床药理学杂志, 2018,23(34):2775-2777. [3] 卢姗,李立,石蕊,等. 盐酸莫西沙星注射液致静脉炎1例[J]. 中国药师, 2018, 5(21):887-888. [4] 杨晓娟,关月,恽艳琴,等. 我院33例莫西沙星不良反应分析[J]. 中国药师, 2018, 12(21):2192-2195. [5] 李远,孙溆棋,张良海,等. 莫西沙星致不良反应165例分析[J]. 药物流行病学杂志, 2014, 7(23):428-430. [6] Culley C M, Lacy M K, Klutman N, et al.Moxifloxacin: clinicaleffica-cy and safety[J]. Am J Health Syst Pharm, 2001,58(5): 379-388. [7] 刘建平. 生物药剂学与药物动力学[M]. 北京:人民卫生出版社,2017年:107. [8] CHERER K,BIRCHER A J.Hypersensitivity reactionsto fluoro-quinolones[J]. Curr Allergy Asthma Rep,2005,25(5):15-21. [9] 许红玮,郑弘. 莫西沙星不良反应70例文献分析[J]. 中国药房,2010,21(36):3433-3434. [10] 祁琳. 莫西沙星引起的不良反应及分析[C]//2012年中国药学大会暨第十二届中国药师周论文集.北京:中国药学会,2012:3. [11] 李新. 左氧氟沙星致呼吸困难等不良反应1例[J]. 天津药学,2007,5(19):40-41. |
| [1] | LI Xinying, BAO Lei, LI Shuran, ZHAO Ronghua, SUN Jing, XIE Dan, BAO Yanyan, GUO Shanshan, CUI Xiaolan, GENG Zihan. Effect of Shufeng Jiedu Capsules on the Production of Specific Antibodies against Influenza A H1N1 Virus and the Mechanisms [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 841-850. |
| [2] | WANG Xinwei, PENG Yifeng, SUN Jing, JI Zuen, BAO Lei, LUO Henglei, GENG Zihan, ZHANG Hujuan, LI Shuran, ZHANG Jingsheng, GUO Shanshan, CUI Xiaolan, ZHAO Ronghua. Effect of Yiye Anti-Influenza Capsules on Pneumonia Induced by Human Coronavirus 229E Infection in Mice [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 851-855. |
| [3] | XIE Rui, SUN Qiyue, LI Yanying, ZHANG Jingsheng, ZHAO Ronghua, GUO Shanshan, GENG Zihan, BAO Lei, GAO Shuangrong, CUI Xiaolan, XIE Dan, SUN Jing. Impacts of Shuangshenling Granules on a Cadmium-Induced Chronic Renal Failure Model of Mice [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 856-862. |
| [4] | CHEN Siying, DING Xueli, LIU Shujia, ZHANG Xiaomeng, ZHANG Bing, LIN Zhijian. Modeling for Prediction of Cardiotoxicity of Chinese Herbal Medicines [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 869-875. |
| [5] | CAI Haili, ZHANG Xiaomeng, LIU Yadi, CHEN Lijuan, WANG Yu, ZHANG Bing. Preventive Strategies for Anthracycline-Induced Cardiotoxicity Using Traditional Chinese Medicine via Ferroptosis Regulation [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 876-882. |
| [6] | ZHENG Haiyun, WANG Zhigang, WU Hongwei, WANG Shaonan, WANG Bin. Identification of in vitro and in vivo Chemical Constituents of Buxin Anmian Decoction Based on UPLC-Q Exactive Orbitrap HRMS [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 883-888. |
| [7] | SUN Ya, WANG Xu, SUN Zhi, ZHOU Yubing. Dose Analysis of Linezolid in Severe Patients with Sepsis Complicated with Acute Kidney Injury [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 889-895. |
| [8] | SHI Qi, WANG Jianxin, WANG Guijie, LU Yueyang, ZHU Jiaxu, GAO Rui. Adjuvant Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease with Qingqi Huatan Pills: a Systematic Review [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 914-919. |
| [9] | YING Jie, XU Xiaolong, LI Bo, LIU Tengwen, LIU Qingquan. Clinical Applications of Jinhua Qinggan Granules in the Treatment of Mild Influenza: a Meta-Analysis [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 920-923. |
| [10] | KE Xiuqin, HAI Xuewu. 433 Cases of Adverse Drug Reactions Induced by Calcium Dobesilate Capsules [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 924-927. |
| [11] | LIANG Jie. 172 Cases of Adverse Drug Reactions Induced by Antineoplastic Drugs [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 928-932. |
| [12] | LIU Jiang, CHEN Jie, QIU Sihong, LI Na, ZHOU Ying, CHEN Yonggang, LUO Ji. Analysis of Adverse Drug Event Induced by Omacycline and Moxifloxacin Based on FAERS Databse [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 933-936. |
| [13] | ZHAO Mudan, ZHU Minghui, ZHANG Huan, ZHAO Yuanyang, QIN Jing. Pharmaceutical Care of a Case of Diabetic Foot Infection Caused by Proteus penneri [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 937-940. |
| [14] | ZHOU Yujie, HUANG Xiaojing, CHEN Mingyue, DU Pengqiang, WANG Aifeng. Two Cases of Severe Thrombocytopenia Caused by Cefoperazone Sulbactam Sodium [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 941-943. |
| [15] | CHEN Huabao, LIU Wei, JIANG Ting, ZHENG Lingli, LI Jing. One Case of Acute Withdrawal Syndrome Caused by Naloxone [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 944-946. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
